Manager, Accounting

The role

The Accounting Manager will report to the Director of Accounting and contribute to various accounting and finance activities. This role involves preparing journal entries, managing month-end closes, and supporting tax filings and internal controls.

What you will do

• Prepare monthly journal entries, support schedules, account reconciliations, and other analyses.
• Prepare and maintain accounting schedules and transaction support for multiple collaboration arrangements.
• Contribute to quarterly accrual meetings and journal entry preparation.
• Manage assigned responsibilities within month-end and quarter-end closes.
• Support the company's annual tax return filing and reporting processes.
• Execute and maintain internal controls over financial reporting.
• Assist with accounting and finance process improvements.
• Crosstrain on payroll processing and serve as backup equity administrator.
• Assist with ad hoc projects and initiatives.
• Collaborate with finance team members and other departments.

Required qualifications

• Bachelor's degree or higher in accounting or related area.
• 5+ years of relevant experience.
• Extremely well-organized and goal-oriented.
• Willingness to be responsible for and perform tasks over a wide spectrum.
• Strong analytical and problem-solving skills.
• Exceptional attention to detail.
• Exceptional work ethic and unquestionable integrity.
• Excellent Excel and other Microsoft Office application skills.
• Excellent written and verbal communication skills.
• Ability to utilize AI tools for day-to-day work; baseline proficiency is expected.
• Able to work on-site and attend in-person meetings.

Nice to have

• Experience in public and/or biopharmaceutical company.
• CPA.
• Experience with NetSuite/Concur/ADP/FloQast.
• Advanced or innovative use of AI is a strong plus.

Benefits

• Annual target bonus
• Equity
• Comprehensive suite of competitive benefits

About the company

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating medicines for patients with serious diseases by unlocking biologically important targets. The company has pioneered a new class of alpha-helical peptides called Helicons™.